- 01/09/2019 - 01/03/2023
- Samuel Schumacher (Foundation for Innovative New Diagnostics, FIND, Switzerland)
- Funded by
The proposed trials will demonstrate (i) the impact of Omni/Ultra and Omni/XDR at a microscopy-centre level on patient-important outcomes; (ii) the impact of Ultra testing of pulmonary and extra-pulmonary samples on mortality in patients with advanced HIV; (iii) the utility of process innovation and supportive solutions for diagnostics (e.g. connectivity) to improve linkage to care, surveillance, stock and device management; and (iv) the needs for staffing, training, stock management and maintenance for implementation of a molecular test at microscopy centre level. Furthermore, it will enable socio-economic and population level impact modelling.
The trial is designed to provide evidence for the most impactful implementation strategies depending on local epidemiology and existing infrastructure, rather than just providing evidence on technology introduction. As such, the work outlined in the proposal aims to support the policy-making mandate of WHO and participating ministries of health and implementation planning for scale-up. Further, the project will establish centres of excellence for the implementation of diagnostic trials that will serve in the evaluation of future tests.
Other projectsSee Past Projects
Combating Bacterial Resistance In Europe
Application to medical devices
Combatting Bacterial Resistance in Europe - Carbapenem Resistance
Prioritising Antimicrobial Resistance: establishing an interdisciplinary International Research Partnership to tackle an evolving global health threat
An interdisciplinary International Research Partnership to tackle an evolving global health threat
Development of new metal-antibiotics against pathogens causing chronic infections in patients with cystic fibrosis.
New metal-antibiotics for patients with cystic fibrosis
Non-invasive ultrasound-based screening for meningitis: Proof-of concept in infants
Improved case detection through TB contact risk stratification by Xpert results and spatial parameters in Mozambique
Evaluation of the effect of weekly high dose rifapentine and isoniazid (3HP) vs periodic 3HP vs 6H for preventing TB among HIV-positive individuals
Search for new target proteins and use of antibacterial or inhibitory peptides against resistance mechanisms in 'Acinetobacter baumannii'
Optimizing provider-initiated HIV testing, linkage, and retention in care in the district of Manhiça, Mozambique
Integrating and decentralizing diabetes and hypertension services in Africa
Searching the hidden: evaluating dengue, chikungunya and Zika autochthonous transmission in the city of Barcelona.
Eficacia de hidroxicloroquina en la prevención de la infección por SARS-CoV-2 y de la gravedad de la enfermedad de COVID-19 durante el embarazo
Pilot Study to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission
Cendea de Cizur
Conèixer la propagació. Entendre la protecció
A breakthrough device for the rapid detection of antimicrobial resistance
Large Clinical Trial in Africa on the Treatment of Mild Cases of COVID-19
Hepatitis B Virus COMmunity Screening and Vaccination in Africans
Evaluating a new stool based qPCR for diagnosis of tuberculosis in children and people living with HIV
Eliminating hepatitis C on the Balearic Islands (Mallorca, Menorca and Ibiza): a study in governmental and non-governmental addiction service centres, a mobile methadone unit and a prison to test and link people who use drugs to HCV care.